72 related articles for article (PubMed ID: 23925888)
1. Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera.
Alam MM; Riyadh MA; Fatema K; Rahman MA; Akhtar N; Ahmed T; Chowdhury MI; Chowdhury F; Calderwood SB; Harris JB; Ryan ET; Qadri F
Clin Vaccine Immunol; 2011 May; 18(5):844-50. PubMed ID: 21346055
[TBL] [Abstract][Full Text] [Related]
2. Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants.
Dash P; Hakim A; Akter A; Banna HA; Kaisar MH; Aktar A; Jahan SR; Ferdous J; Basher SR; Kamruzzaman M; Chowdhury F; Akter A; Tauheed I; Weil AA; Charles RC; Calderwood SB; Ryan ET; LaRocque RC; Harris JB; Bhuiyan TR; Qadri F
mSphere; 2024 Mar; 9(3):e0056523. PubMed ID: 38391226
[TBL] [Abstract][Full Text] [Related]
3. Development of immunoglobulin M memory to both a T-cell-independent and a T-cell-dependent antigen following infection with Vibrio cholerae O1 in Bangladesh.
Kendall EA; Tarique AA; Hossain A; Alam MM; Arifuzzaman M; Akhtar N; Chowdhury F; Khan AI; Larocque RC; Harris JB; Ryan ET; Qadri F; Calderwood SB
Infect Immun; 2010 Jan; 78(1):253-9. PubMed ID: 19858296
[TBL] [Abstract][Full Text] [Related]
4. Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera.
Kaisar MH; Bhuiyan MS; Akter A; Saleem D; Iyer AS; Dash P; Hakim A; Chowdhury F; Khan AI; Calderwood SB; Harris JB; Ryan ET; Qadri F; Charles RC; Bhuiyan TR
mSphere; 2021 Apr; 6(2):. PubMed ID: 33910997
[TBL] [Abstract][Full Text] [Related]
5. Augmented immune responses to a booster dose of oral cholera vaccine in Bangladeshi children less than 5 years of age: Revaccination after an interval of over three years of primary vaccination with a single dose of vaccine.
Chowdhury F; Bhuiyan TR; Akter A; Bhuiyan MS; Khan AI; Tauheed I; Ahmed T; Ferdous J; Dash P; Basher SR; Hakim A; Lynch J; Kim JH; Excler JL; Kim DR; Clemens JD; Qadri F
Vaccine; 2020 Feb; 38(7):1753-1761. PubMed ID: 31879124
[TBL] [Abstract][Full Text] [Related]
6. Noncovalent antibody catenation on a target surface greatly increases the antigen-binding avidity.
Song J; Jeong BS; Kim SW; Im SB; Kim S; Lai CJ; Cho W; Jung JU; Ahn MJ; Oh BH
Elife; 2023 May; 12():. PubMed ID: 37249578
[TBL] [Abstract][Full Text] [Related]
7. Determination of Binding Affinity of Antibodies to HIV-1 Recombinant Envelope Glycoproteins, Pseudoviruses, Infectious Molecular Clones, and Cell-Expressed Trimeric gp160 Using Microscale Thermophoresis.
Basu S; Gohain N; Kim J; Trinh HV; Choe M; Joyce MG; Rao M
Cells; 2023 Dec; 13(1):. PubMed ID: 38201237
[TBL] [Abstract][Full Text] [Related]
8. Daily preventive zinc supplementation increases the antibody response against pathogenic Escherichia coli in children with zinc insufficiency: a randomised controlled trial.
Kewcharoenwong C; Sein MM; Nithichanon A; Khongmee A; Wessells KR; Hinnouho GM; Barffour MA; Kounnavong S; Hess SY; Stephensen CB; Lertmemongkolchai G
Sci Rep; 2022 Sep; 12(1):16084. PubMed ID: 36167891
[TBL] [Abstract][Full Text] [Related]
9. HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial.
Tsang SH; Schiller JT; Porras C; Kemp TJ; Herrero R; Schussler J; Sierra MS; Cortes B; Hildesheim A; Lowy DR; Rodríguez AC; Romero B; Çuburu N; Shing JZ; Pinto LA; Sampson JN; Kreimer AR;
NPJ Vaccines; 2022 Mar; 7(1):40. PubMed ID: 35351898
[TBL] [Abstract][Full Text] [Related]
10. Profiling the Quality and Quantity of Naturally Induced Antibody Responses Against Pfs230 and Pfs48/45 Among Non-Febrile Children Living in Southern Ghana: A Longitudinal Study.
Broni FK; Acquah FK; Obiri-Yeboah D; Obboh EK; Sarpong E; Amoah LE
Front Cell Infect Microbiol; 2021; 11():770821. PubMed ID: 34900755
[TBL] [Abstract][Full Text] [Related]
11. Systemic, Mucosal, and Memory Immune Responses following Cholera.
Ryan ET; Leung DT; Jensen O; Weil AA; Bhuiyan TR; Khan AI; Chowdhury F; LaRocque RC; Harris JB; Calderwood SB; Qadri F; Charles RC
Trop Med Infect Dis; 2021 Oct; 6(4):. PubMed ID: 34842841
[No Abstract] [Full Text] [Related]
12. Antibodies to neurofilament light as potential biomarkers in multiple sclerosis.
Puentes F; Benkert P; Amor S; Kuhle J; Giovannoni G
BMJ Neurol Open; 2021; 3(2):e000192. PubMed ID: 34786556
[TBL] [Abstract][Full Text] [Related]
13. Zika Virus Envelope Domain III Recombinant Protein Delivered With Saponin-Based Nanoadjuvant From
Cibulski S; Varela APM; Teixeira TF; Cancela MP; Sesterheim P; Souza DO; Roehe PM; Silveira F
Front Immunol; 2021; 12():632714. PubMed ID: 33746970
[TBL] [Abstract][Full Text] [Related]
14. Modelling the roles of antibody titre and avidity in protection from Plasmodium falciparum malaria infection following RTS,S/AS01 vaccination.
Thompson HA; Hogan AB; Walker PGT; White MT; Cunnington AJ; Ockenhouse CF; Ghani AC
Vaccine; 2020 Nov; 38(47):7498-7507. PubMed ID: 33041104
[TBL] [Abstract][Full Text] [Related]
15. Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysaccharide antigen in Haitian adults.
Falkard B; Charles RC; Matias WR; Mayo-Smith LM; Jerome JG; Offord ES; Xu P; Kováč P; Ryan ET; Qadri F; Franke MF; Ivers LC; Harris JB
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007057. PubMed ID: 30703094
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and Protection From a Single Dose of Internationally Available Killed Oral Cholera Vaccine: A Systematic Review and Metaanalysis.
Lopez AL; Deen J; Azman AS; Luquero FJ; Kanungo S; Dutta S; von Seidlein L; Sack DA
Clin Infect Dis; 2018 Jun; 66(12):1960-1971. PubMed ID: 29177437
[TBL] [Abstract][Full Text] [Related]
17. Cholera toxin B: one subunit with many pharmaceutical applications.
Baldauf KJ; Royal JM; Hamorsky KT; Matoba N
Toxins (Basel); 2015 Mar; 7(3):974-96. PubMed ID: 25802972
[TBL] [Abstract][Full Text] [Related]
18. Antibody avidity in humoral immune responses in Bangladeshi children and adults following administration of an oral killed cholera vaccine.
Alam MM; Leung DT; Akhtar M; Nazim M; Akter S; Uddin T; Khanam F; Mahbuba DA; Ahmad SM; Bhuiyan TR; Calderwood SB; Ryan ET; Qadri F
Clin Vaccine Immunol; 2013 Oct; 20(10):1541-8. PubMed ID: 23925888
[TBL] [Abstract][Full Text] [Related]
19. Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection.
Alam MM; Arifuzzaman M; Ahmad SM; Hosen MI; Rahman MA; Rashu R; Sheikh A; Ryan ET; Calderwood SB; Qadri F
Clin Vaccine Immunol; 2013 Jan; 20(1):17-23. PubMed ID: 23114701
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
